- Home
- TLX
TLX
Telix Pharmaceuticals Limited American Depositary Shares
as 12-18-2024 9:44am EST
| Founded: | 2015 | Country: | Australia |
| Employees: | N/A | City: | N/A |
| Market Cap: | 5.0B | IPO Year: | N/A |
| Target Price: | $21.00 | AVG Volume (30 days): | 18.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.44 - $19.99 | Next Earning Date: | 01-01-0001 |
| Revenue: | $430,795,970 | Revenue Growth: | 80.92% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Telix Pharmaceuticals Limited American Depositary Shares News
TLX Breaking Stock News: Dive into TLX Ticker-Specific Updates for Smart Investing
Compare TLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TLX Telix Pharmaceuticals Limited American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.